๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Premalignant and early malignant lesions of the prostate

โœ Scribed by David G. Bostwick

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
67 KB
Volume
50
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Immunohistochemical staining for DNA top
Immunohistochemical staining for DNA topoisomerase II-alpha in benign, premalignant, and malignant lesions of the prostate
โœ Willman, Joseph H.; Holden, Joseph A. ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 455 KB ๐Ÿ‘ 2 views

## BACKGROUND. The DNA topoisomerase II-alpha (topo II-alpha)-targeting drug etoposide was recently shown to be an active agent in the combined chemotherapy of hormoneinsensitive prostatic carcinoma. Aside from being the molecular target of etoposide, topo II-alpha is also a cell proliferation mark

Premaliganant and early malignant lesion
Premaliganant and early malignant lesions of the bladder
โœ David G. Bostwick ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 64 KB

## PREMALIGNANT AND EARLY MALIGNANT LESIONS OF THE BLADDER The first session of the conference defined the spectrum of putative premalignant and early malignant lesions of the bladder. Two distinct non-invasive lesions were discussed which have different clinical and biologic potential. The first,

Premalignant lesions of the breast
Premalignant lesions of the breast
โœ Charles W. Boone ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 68 KB

## Premalignant Lesions of the Breast In this session the histological, clinical, and epidemiological features of proliferative lesions of the breast are presented. Dr. Roy Jensen describes the criteria of Dupont and Page for making the diagnosis of proliferative breast lesions. Dupont and Page us